Artificial Intelligence in Pediatrics: Transforming Healthcare for Children

0
0
0

Artificial Intelligence in Pediatrics: Transforming Healthcare for Children

Introduction

In today’s digital age, the rapid progress of information technology has brought about remarkable advancements in artificial intelligence (AI), big data processing, and cloud computing. These technological breakthroughs have had a profound impact on the traditional healthcare industry, revolutionizing its structure and efficiency, and playing a crucial role in the establishment and maintenance of modern medical management information systems.

AI has emerged as a powerful tool in the medical field, offering innovative solutions for handling various types of medical data. Electronic medical records, medical imaging technology, medical big data, intelligent drug design, and smart health management systems are just a few examples of how AI is being applied to improve the standardization and accuracy of clinical decision-making. By providing more dimensions of data accumulation for medical knowledge-based systems, AI enables physicians and researchers to optimize treatment plans and make more informed decisions about the best treatment options for patients.

This review aims to summarize the recent advances in the research and clinical use of AI in pediatrics. We will explore how AI is being used to improve the diagnosis and treatment of pediatric diseases, enhance neonatal care, and support the early identification of autism. We will also discuss the challenges and opportunities associated with the development and implementation of AI in pediatrics and the potential impact it may have on the future of pediatric healthcare.

AI in Medical Research Using Clinical Databases

One of the most promising applications of AI in pediatrics is in medical research using clinical databases. Clinical databases contain a wealth of information about patients, including their medical history, symptoms, test results, and treatment outcomes. By analyzing this data using AI algorithms, researchers can identify patterns and trends that may not be apparent through traditional research methods.

Identifying Subtypes of Sepsis

Sepsis is a life-threatening condition that affects many children. Early diagnosis and treatment are crucial for improving outcomes. A research group successfully identified four subtypes of sepsis from 6708 pediatric cases using natural language processing (NLP), deep auto-encoding, and unsupervised clustering. These four subtypes presented distinctive clinical features, and the testing results coincided accurately with clinical features, which enhanced the rationality and reliability of the clustering results.

The model developed by this research group is capable of handling multiple model data lists at the same time. It not only includes structural data such as demographic characteristics and laboratory tests but also extracts useful information from unstructured data such as medical records and image reports. The analysis results of this model tally with clinical retrospective research results, indicating its potential for improving the diagnosis and treatment of sepsis in children.

Improving the Diagnosis of Pediatric Pulmonary Hypertension

Pediatric pulmonary hypertension (PH) is a rare but serious condition that can lead to heart failure and death. Early diagnosis and treatment are essential for improving outcomes. Gomberg-Maitland and Souza (2017) used AI with deep machine learning to improve the diagnosis of pediatric PH and related diseases. They performed a general analysis through comparative statistical methods and established a Bayesian research network to analyze 186 children suffering from PH and without PH.

The Bayesian research network developed by Gomberg-Maitland and Souza eliminates the relationship between dependence and independence and evaluates the possibility of complications. This technique can be used in clinical research to improve the accuracy of diagnosis and treatment. In addition, the authors used AI technology such as a noisy-OR model, bootstrap modeling, and network clustering, which allowed them to reduce the noise and increase the diagnostic validity.

The networks developed by Gomberg-Maitland and Souza were further evaluated by doctors and one investigator who reviewed the inter-rater validity and dealt with discrepancies based on the statisticians’ and doctors’ concerns. A literature review was conducted to analyze and evaluate the clinical reliability of the findings. The AI analysis focused on pediatric PH not only verified the existing mature subtype classification system but also identified the uncommon subtypes in only a few case studies, in accord with rare genetic syndromes, which are excluded in the system.

Investigating the Relationship Between Brain Volume Overgrowth and Autistic Social Deficits

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder that affects many children. Early identification and intervention are crucial for improving outcomes. In investigating the relationship between brain volume overgrowth and autistic social deficits (ASDs), the investigators conducted a prospective study, in which 106 infants at high familial risk of ASD and 42 low-risk infants were included, using the deep-learning algorithm.

Surface area information was obtained using magnetic resonance imaging of the brains of individuals at the age of 6 to 12 months old to predict the diagnostic validity of pediatric autism at 2 years. The results revealed a predictive sensitivity of 88%, with an acceptable positive predictive value. The application of AI technology enabled confirmation of the relationship between early brain changes and autism-related behaviors, and is expected to support the early identification of autism.

AI in Neonatal Daily Care

The application of AI in neonatal daily care is also an important medical scenario. Newborns are vulnerable and require close monitoring to ensure their health and well-being. AI can be used to monitor newborns’ vital signs, detect early signs of illness, and provide timely interventions.

Monitoring Newborn Jaundice

Newborn jaundice is a common condition that affects many newborns. If left untreated, it can lead to serious complications such as brain damage. An information system was established with the help of mobile phones for the purpose of monitoring newborn jaundice, and k-nearest neighbor (KNN), least angle regression (LARS), fusion of Least Absolute Shrinkage and Selection Operator (LARS-Lasso) Elastic Net, ridge regression, random forest support, and vector regression have been applied in machine learning algorithms.

In Aydın et al’s neonatal jaundice detection system, at the stage of estimating bilirubin levels, the KNN and support vector regression algorithms are used to regress the feature-extracted data sets. In addition, Hao et al proposed an intelligent system for diagnosing newborn jaundice with a dynamic uncertain causality graph model. The accelerated establishment of large amounts of healthcare data has fundamentally changed the nature of healthcare. Some researchers have applied AI in the genetic analysis of congenital cleft lip and palate, with promising progress.

AI in the Diagnosis of Common Pediatric Diseases

For diagnoses of common diseases that can benefit from many cases, engineers can accumulate data regarding symptoms, test indexes, routine care, treatments and responses, follow-up, and prognosis. Using these big data sets, a number of AI-based diagnostic models have been developed.

Childhood Asthma

Childhood asthma is a common chronic disease that affects many children. Early diagnosis and treatment are crucial for improving outcomes. A diagnostic model for childhood asthma was established based on four machine learning models, three of which were found to operate effectively using pre-formed decision trees. The addition of weighting, social and economic status and weather data were found to enhance the models’ performance.

Community-Acquired Pneumonia

Community-acquired pneumonia is a common respiratory infection that affects many children. Early diagnosis and treatment are crucial for improving outcomes. A model of community-acquired pneumonia in children has been trained successfully to recognize various types of abnormal image retrospectively.

Challenges and Opportunities in the Development and Implementation of AI in Pediatrics

While AI has the potential to transform pediatric healthcare, its development and implementation also face several challenges. Standardized data collection, quality management, information sharing, privacy protection, regulatory policies, and ethical considerations are some of the challenges that need to be addressed.

Standardized Data Collection

Standardized data collection is essential for the development and implementation of AI in pediatrics. However, medical data is often collected in different formats and from different sources, making it difficult to integrate and analyze. To address this challenge, healthcare providers need to adopt standardized data collection methods and use interoperable medical record systems.

Quality Management

Quality management is another challenge in the development and implementation of AI in pediatrics. AI algorithms are only as good as the data they are trained on. If the data is inaccurate or incomplete, the AI algorithms may produce incorrect results. To ensure the quality of data, healthcare providers need to implement data quality management processes and use data validation techniques.

Information Sharing

Information sharing is crucial for the development and implementation of AI in pediatrics. Healthcare providers need to share data with researchers and other stakeholders to develop and validate AI algorithms. However, information sharing can also raise privacy concerns. To address this challenge, healthcare providers need to implement privacy protection measures and use secure data sharing platforms.

Privacy Protection

Privacy protection is a major concern in the development and implementation of AI in pediatrics. Medical data is sensitive and contains personal information about patients. If this data is not protected, it can be misused or accessed by unauthorized parties. To ensure the privacy of patients, healthcare providers need to implement privacy protection measures and use encryption techniques.

Regulatory Policies

Regulatory policies are also important in the development and implementation of AI in pediatrics. AI algorithms need to be regulated to ensure their safety and effectiveness. However, the regulatory landscape for AI in healthcare is still evolving. To address this challenge, healthcare providers need to work with regulators to develop appropriate regulatory policies.

Ethical Considerations

Ethical considerations are another challenge in the development and implementation of AI in pediatrics. AI algorithms can make decisions that have a significant impact on patients’ lives. Therefore, it is important to ensure that these decisions are made ethically and in the best interests of patients. To address this challenge, healthcare providers need to implement ethical guidelines and use ethical decision-making frameworks.

Conclusion

In conclusion, AI has the potential to transform pediatric healthcare by improving the diagnosis and treatment of pediatric diseases, enhancing neonatal care, and supporting the early identification of autism. However, its development and implementation also face several challenges, including standardized data collection, quality management, information sharing, privacy protection, regulatory policies, and ethical considerations.

To overcome these challenges, healthcare providers, researchers, and policymakers need to work together to develop and implement appropriate strategies and policies. By doing so, we can ensure that AI is used in a safe, effective, and ethical manner to improve the health and well-being of children.

References

  1. Kamaleswaran R, Akbilgic O, Hallman MA, West AN, Davis RL, Shah SH. Applying artificial intelligence to identify physiomarkers predicting severe sepsis in the PICU. Pediatr Crit Care Med 2018;19: e495–e503. doi: 10.1097/PCC.0000000000001666.
  2. Liu GJ, Li XJ, Li QF, Zheng JB, Li LJ, Cao XJ, et al. Childhood sepsis subtype recognition driven by clinical phenotype data and medical knowledge [in Chinese]. Chin Digit Med 2019;14:66–69. doi: 10.3969/j.issn.1673-7571.2019.03.019.
  3. Gomberg-Maitland M, Souza R. Uncovering small secrets in big data sets: how math can identify biology in rare conditions (pediatric pulmonary hypertension). Circ Res 2017;121:317–319. doi: 10.1161/CIRCRESAHA.117.311511.
  4. Hazlett HC, Gu H, Munsell BC, Elison JT, Wolff JJ, Swanson MR, et al. Early brain development in infants at high risk for autism spectrum disorder. Nature 2017;542:348–351. doi: 10.1186/s11689-018-9247-8.
  5. De Greef L, Goel M, Seo MJ, Larson EC, Stout JW, Taylor JA, et al. Bilicam: using mobile phones to monitor newborn jaundice. UbiComp ’14 Proceedings of the 2014 ACM International Joint Conference on Pervasive and Ubiquitous Computing, 2014, pp. 331-342.
  6. Aydın M, Hardalaç F, Ural B, Karap S. Neonatal jaundice detection system. J Med Syst 2016;40:166–176. doi: 10.1007/s10916-016-0523-4.
  7. Hao SR, Geng SC, Fan LX, Chen JJ, Zhang Q, Li LJ. Intelligent diagnosis of jaundice with dynamic uncertain causality graph model. J Zhejiang Univ Sci B 2017;18:393–401. doi: 10.1631/jzus.B1600273.
  8. Zhang SJ, Meng P, Zhang J, Jia P, Lin J, Wang X, et al. Machine learning models for genetic risk assessment of infants with non-syndromic orofacial cleft. Genom Proteom Bioinformat 2018;16: 354–364. doi: 10.1016/j.gpb.2018.07.005.
  9. Rajkomar A, Dean J, Kohane I. Machine learning in medicine. New Eng J Med 2019;380:1347–1358. doi: 10.1056/NEJMra1814259.
  10. Wu JZ, Luo Z, Xu S, Su PC, Yuan W, Li YX, et al. Realize the intelligent auxiliary diagnosis of pediatric clinical disease with the application of deep learning [in Chinese]. Chin Digit Med 2018;13: 14–16. doi: 10.3969/j.issn.1673-7571.2018.10.005.
  11. Li XZ, Wang HZ, Xiong YJ, Zeng YC, He T, Wu JZ, et al. Application of convolutional neural network in pediatric disease prediction [in Chinese]. Chin Digit Med 2018;13:11–13. doi: 10.3969/j.issn.1673-7571.2018.10.004.
  12. Patel SJ, Chamberlain DB, Chamberlain JM. A machine learning approach to predicting need for hospitalization for pediatric asthma exacerbation at the time of emergency department triage. Acad Emerg Med 2018;25:1463–1470. doi: 10.1111/acem.13655.
  13. Zhao QS, Tai J, Zhao SY, Xie XH, Ni X. Design of intelligent assistant diagnosis system for children’s community acquired pneumonia [in Chinese]. Chin J Health Informat Manag 2018; 15:465–468. doi: 10.3969/j.issn.1672-5166.2018.04.023.
  14. Wahl B, Cossy-Gantner A, Germann S, Schwalbe NR. Artificial intelligence (AI) and global health: how can AI contribute to health in resource-poor settings? BMJ Glob Health 2018;3:e000798–e000805. doi: 10.1136/bmjgh-2018-000798.
  15. Kayaalp M. Patient privacy in the era of big data. Balkan Med J 2018;35:8–17. doi: 10.4274/balkanmedj.2017.0966.

doi: 10.1097/CM9.0000000000000563

Was this helpful?

0 / 0